brightlight schreef op 26 augustus 2020 10:06:
I have no idea why the MSI test was not included in the China inter lab quality assessment. Maybe because MSI falls under a different category of gene mutation tests that were not included in the inter lab study. Who knows?
Concerning the 400 consoles. Indeed some of them may have been placed in 2019, but considering that the total number of consoles newly installed for the whole of last year was only 337, I cannot imagine that the China number was very high. Besides I cannot recall that China was ever mentioned as a large contributor to sales last year. In Q1 of this year 40% of console sales came from the U.S. No mention of China either. This gives us two options. Either the China press release gives us the wrong impression, or the bulk of the 400 consoles was placed in Q2'20, which doesn't seem realistic because surely the inter-lab study has started way earlier?
Still the press release seems quite specific:
"All three (Wanfu Cartis) projects passed full marks, ... . These three projects cover more than 30 provinces (municipalities, autonomous regions) across the country, of which more than 400 laboratories participated in EGFR alone, ... ."
Another enigma to add to the list.